companydata.dkcompanydata.dk

ABL BIOTEC A/S: Financial statements 2018

CVR: 50811018

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -109,236 and a net result of DKK -1,956,129 compared with DKK 1,139,039 the year before. Equity in the 2018 report amounted to DKK 21,521,493. The solvency ratio was 99.1%. The company had 1 employee in the financial year.

Gross Profit
DKK -109,236
Profit/Loss
DKK -1,956,129
Equity
DKK 21,521,493
Total Assets
DKK 21,726,194
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--109 t.-2 mio.21.5 mio.1
2017--125 t.1.1 mio.24.6 mio.1
2016--118 t.796 t.24.5 mio.1
2015--122 t.2.2 mio.24.8 mio.-
2014--100 t.3.8 mio.23.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

ABL BIOTEC A/S: The 2017 annual report is outMay 16, 2018

ABL BIOTEC A/S has published its annual report for 2017. Gross profit came to DKK -125,116, and the net result was DKK 1,139,039.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.

Source: annual report 2025, Danish Business Authority